Synabs

Developer of monoclonal antibody platform against poor immunogenic compounds

placeCharleroi, Wallonia, Belgium calendar_todayFounded 2015 groups8 employees language synabs.be

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 101 times.

YearFilings
20241
20251

Social engagement

Social engagement: 2.2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Accelerator & incubator120%
Other / undisclosed480%

Recent activity

12 Feb 2026
Product launch
SYnAbs monoclonal antibody panel for HbE detection
12 Nov 2025
Event
MEDICA 2025
Coming soon